Michael A. Young, MHA, FACHE, President and CEO of Temple University Hospital and Temple University Health System, provided perspective to Becker’s Hospital Review on “one question that hospital CEOs need answered right now.”
Michael A. Young, MHA, FACHE, President and CEO of Temple University Hospital and Temple University Health System, provided perspective to Becker’s Hospital Review on “one question that hospital CEOs need answered right now.”
Data found oral ralinepag significantly reduced the risk of first clinical worsening in low-risk patients with pulmonary arterial hypertension already receiving contemporary background therapy.
View DetailsMohammed Andaleeb Chowdhury, MD, spoke with ConsultantLive and HCPLive about his presentation at the Pulmonary Hypertension Association International PH Conference and Scientific Sessions.
View Details